In this Oncology Brothers podcast episode, Naval Daver, MD, MD Anderson Cancer Center, Houston, Texas, discusses treatment strategies for both therapy‑related and de novo acute myeloid leukemia (AML), focusing on cases…
Tara Lin, MD, University of Kansas Medical Center, Kansas City, Kansas, discusses how she approaches choosing induction therapy for patients with treatment-related acute myeloid leukemia, emphasizing that fitness…
NEW YORK (Reuters Health) – Patients with severe cases of novel H1N1 influenza virus infection (swine flu) are at heightened risk for chest complications, including pulmonary emboli, Michigan…
The following webcasts feature experts in the field of venous thromboembolism (VTE) prevention. Topics cover several aspects of VTE prevention today, including VTE prevalence, patient risk factors, the…
The following webcasts feature experts in the field of venous thromboembolism (VTE) prevention. Topics cover several aspects of VTE prevention today, including VTE prevalence, patient risk factors, the…
The following webcasts feature experts in the field of venous thromboembolism (VTE) prevention. Topics cover several aspects of VTE prevention today, including VTE prevalence, patient risk factors, the…
The following webcasts feature experts in the field of venous thromboembolism (VTE) prevention. Topics cover several aspects of VTE prevention today, including VTE prevalence, patient risk factors, the…
NEW YORK (Reuters Health) – Neoadjuvant treatment with erlotinib (Tarceva), an epidermal growth factor receptor (EGFR) inhibitor, can help downstage bladder cancer to organ-confined disease, thereby increasing the…
NEW YORK (Reuters Health) – Coronary angiography is a recommended screening test for many patients undergoing kidney transplantation and now new research shows that it can be performed…
NEW YORK (Reuters Health) – Deferring percutaneous coronary intervention (PCI) and treating high-risk heart disease patients with optimal medical therapy alone does not increase the risk of death,…
NEW YORK (Reuters Health) – Treatment with the third generation bisphosphonate zoledronic acid (Zometa) may improve survival in lung cancer patients with bone metastases, Greek researchers report. Between…
